TCMBANKIN007068 |
γ-guanidinobutyricacid |
|
C5H11N3O2 |
|
|
TCMBANKIN022518 |
noradrenaline |
l-Norepinephrine bitartrate; 33404-26-1; l-Arterenol d-bitartrate; Norepinephrine hydrogen tartrate; 350-25-4; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt); API0007150; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 341N180; L(+)-TARTARIC ACID; NOREPINEPHRINE; Noradrenalin bitartrate, l-; Arterenol bitartrate; Noradrenaline acid tartrate; MolPort-029-943-999; Norartrinal bitartrate; Levarterenol; ZW81GF408B; Norepinephrine bitartrate anhydrous; L-Noradrenaline bitartrate; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bitartrate salt; AKOS007930222; Noradrenaline, tartrate (1:1); Norepinephrine tartrate; 73-98-3; Noradrenaline bitartrate; Noradrenaline tartrate; l-Noradrenaline tartrate; UNII-ZW81GF408B; C8H11NO3.C4H6O6; (-)-Norepinephrine bitartrate; (-)-Noradrenaline (+)-bitartrate; BG01031160; 51-40-1; 2477-42-1; Levonorepinephrine; 2595AH; l-Noradrenaline d-bitartrate; Noradrenaline hydrogen tartrate; HMS2089E22; (-)-R-Norepinephrine bitartrate; NSC 169106; 51-41-2 (Parent); API0003624; norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1); l-Arterenol bitartrate; Levarterenol bitartrate; Noradrenalin bitartrate; L-(-)-Noradrenaline (+)-bitartrate salt monohydrate; BENZYL ALCOHOL, alpha-(AMINOMETHYL)-3,4-DIHYDROXY-, (-)-, TARTRATE (1:1); 24868-01-7; 893-91-4; EINECS 200-095-0 |
C8H12NO3+ |
170.19 g/mol |
C1=CC(=C(C=C1C(C[NH3+])O)O)O |
TCMBANKIN023589 |
norarmepavine |
L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 |
C18H21NO3 |
299.4 g/mol |
COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |
TCMBANKIN029144 |
adrenaline(i) |
|
C9H13NO3 |
|
CNCC(C1=CC(=C(C=C1)O)O)O |
TCMBANKIN042107 |
Adrenaline |
adrenaline |
|
219.66 g/mol |
|
TCMBANKIN058455 |
GUN |
NCI60_012450; CHEBI:16235; 15986-36-4; nchembio.2007.33-comp3; 2-amino-1,9-dihydro-6H-purin-6-one; Hypoxanthine, 2-amino-; 2-Amino-1,9-dihydro-purin-6-one; Mearlmaid AA; EINECS 200-799-8; HSDB 2127; ZINC00895129; C.I. 75170; C.I. Natural White 1; InChI=1/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11; ST5298917; Guanin; Dew Pearl; BB_NC-1199; 6-Hydroxy-2-aminopurine; 11006-44-3; G6779_SIGMA; C00242; Guanine (8CI); 6H-Purin-6-one, 2-amino-1,7-dihydro-; 73-40-5; Oprea1_875298; AIDS045523; Natural pearl essence; 2-Amino-1,7-dihydro-6H-purin-6-one; SBB004065; GUANINE; 6H-Purin-6-one, 2-amino-1,7-dihydro- (9CI); 2-Amino-6-purinol; 492-33-1; 54435-87-9; Stella Polaris; AIDS-045523; AI3-24393; 2-amino-3,7-dihydropurin-6-one; 2-Aminohypoxanthine; CI Natural white 1; Guanine-8-14C hydrochloride; CI 75170; 2-Amino-6-hydroxy-1H-purine; Natural white 1; G1147_SIGMA; 69257-39-2; 8039-79-0; Guanine enol; Pathocidin; Pearl essence; 2-Amino-6-hydroxypurine; G11950_ALDRICH; ST5298926; Mearlmaid; 6H-purin-6-one, 2-amino-3,7-dihydro-; 37432-34-1; 2-Amino-4H-purin-6-ol; AKOS027419119; 2-amino-1H-purin-6(4H)-one; 6H-Purin-6-one, 2-amino-1,4-dihydro-; 914452-02-1; TC-125087; AK466185; KB-167027 |
C5H5N5O |
151.13 g/mol |
C1=NC2=C(N1)C(=O)NC(=N2)N |
TCMBANKIN061551 |
norarmepavine |
n-norarmepavine; L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 |
C18H21NO3 |
299.4 g/mol |
COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |